Clinical Trials Logo

Constipation clinical trials

View clinical trials related to Constipation.

Filter by:

NCT ID: NCT05980988 Completed - Clinical trials for Chronic Constipation

Effectiveness and Safety of Probiotic in Regulating Chronic Constipation

Start date: September 9, 2021
Phase: N/A
Study type: Interventional

To evaluate the effectiveness and safety of the use of probiotics as food supplements in regulating the intestinal habit of subjects with chronic constipation, in comparison with placebo.

NCT ID: NCT05973721 Recruiting - Pib Specific Phage Clinical Trials

Clinical Study of Phage Therapy for Chronic Constipation Efficacy and Safety

Start date: July 1, 2023
Phase: N/A
Study type: Interventional

The overall aim was to evaluate the efficacy of PiB-specific phages for the treatment of refractory constipation through clinical studies, primarily for the publication of scientific papers and to guide the development of phage therapies. The purpose of this study will be subdivided into three aspects from three aspects: target exposure level, target occupation, and functional effects after acting on the target, including:1) The distribution of PIB phage in the intestine of patients with refractory constipation;2) The killing effect of PIB phage on PIB bacteria in refractory constipation patients;And 3) therapeutic effect of PIB phage on patients with refractory constipation.

NCT ID: NCT05946967 Not yet recruiting - Constipation Clinical Trials

Colon Transit Study for Chronic Constipation Assessment and Therapy by Biofeedback With and Without TENS

TENS
Start date: July 20, 2023
Phase: N/A
Study type: Interventional

One of the most challenging functional gastrointestinal illnesses (FGID) to manage is constipation, which is a widespread issue. The fact that constipation can be caused by a variety of conditions, including slow colon transit, faecal evacuation disorder, or a combination of both slow colon transit and faecal evacuation disorder, is one of the main reasons it is challenging to treat. Treatment options vary based on the pathogenetic mechanism; for instance, biofeedback, botulinum toxin injections in the puborectal sling, or transcutaneous electrical nerve stimulation (TENS) are required to treat faecal evacuation problem. On the other hand, prucalopride and other colokinetic drugs as well as drugs that promote high amplitude propagating contractions, including bisacodyl and sodium pyrosulphate, are used to treat slow transit constipation. Sometimes faecal evacuation disorders that inhibit the evacuation of the transit markers can cause slow colon transit times; these secondary sluggish colon transit times have been shown to improve with biofeedback therapy alone. Even though the causes of faecal evacuation disorders are not fully understood, it is known that abnormal neuromuscular function is the result. A few workers have stimulated the posterior tibial nerve, another sacral plexus branch, non-invasively with TENS. Studies on the use of biofeedback in the treatment of patients with faecal evacuation problems are lacking. Accordingly, we wish to undertake a prospective study with following aims: (i) To assess safety and efficacy of colon transit study by an indigenous radio opaque marker to identify the mechanism of constipation and to assess outcome of treatment (improvement of transit time). (ii) To assess the efficacy of pathogenesisdirected therapy such as biofeedback with or without TENS for posterior tibial nerve to treat fecal evacuation disorder. (iii) To assess colon transit following treatment of fecal evacuation disorder with either biofeedback alone or biofeedback with TENS for posterior tibial nerve.

NCT ID: NCT05941650 Not yet recruiting - Clinical trials for Irritable Bowel Syndrome

To Study the Effect of Short-chain Fructooligosaccharides in Women With Irritable Bowel Syndrome

Start date: December 2, 2024
Phase: N/A
Study type: Interventional

To evaluate whether there is clinical improvement through the scales (Bristol, IBS severity score, and IBS quality of life) in women with irritable bowel syndrome after administration of SC-FOS (short-chain fructooligosaccharides).

NCT ID: NCT05923723 Active, not recruiting - Clinical trials for Constipation Chronic Idiopathic

Efficacy of a Dietary Intervention for the Treatment of Constipation in Institutionalized Older Adults. Medellín, 2023-2024.

Start date: March 15, 2024
Phase: N/A
Study type: Interventional

The objective of this clinical trial is to determine if a dietary intervention for the treatment of chronic idiopathic constipation in older adults in the city of Medellin is effective (works well), focusing on the population in geriatric care centers and institutions. The goal is to obtain scientific evidence that allows determining the efficacy of this intervention for the non-pharmacological treatment of constipation in the elderly. The main question to be answered is: "Is a dietary product designed with psyllium, chia, and flaxseed a reliable and effective treatment for managing constipation in older adults?" The intervention and follow-up period for the study has been set at 6 weeks (45 days). During this time, participants will receive orally, once a day (every 24 hours), 1 tablespoon (20g) of the product - FIBNUTRITION - (a natural food product rich in fiber, with its main components being flaxseed, chia, and psyllium), mixed in an 8oz glass (approximately 250ml) of room temperature water using a blender (following the manufacturer's instructions for use). The product will be provided to each patient in the morning before breakfast. The proposed research corresponds to an intervention study, specifically a randomized, controlled, double-blind, multicenter clinical trial. The researchers will compare an intervention group (dietary intervention) with a control group (placebo: a similar product that does not contain fiber or components that can alter the intestinal tract) to observe if there is a difference of at least 40% in the prevalence of satisfactory relief of constipation symptoms (desired primary effect criterion) between the two groups.

NCT ID: NCT05921383 Not yet recruiting - Clinical trials for Constipation-predominant Irritable Bowel Syndrome

Anorectal Manometry of Patients With Constipation Predominant IBS

Start date: July 1, 2023
Phase:
Study type: Observational

The aim of The study is to compare between the anorectal manometric profile of patients with functional constipation and patients with constipation predominant irritabe bowel syndrome

NCT ID: NCT05910021 Recruiting - Clinical trials for Urinary Incontinence

Early Safety of Resection Recopy and Sacrocolpopexy

RRPSCPcomb
Start date: February 1, 2020
Phase:
Study type: Observational

Obstructive defecation syndrome (ODS) defines a disturbed defecation process frequently associated with pelvic organ prolapse (POP) in women. It substantially compromises quality of life and conservative treatment options are limited. In cases surgery is required the interventions are characterized by individual approaches. Laparoscopic resection rectopexy (L-RRP) combined with laparoscopic sacrocolpopexy (L-SCP) was established in an interdisciplinary setting.

NCT ID: NCT05906186 Not yet recruiting - Constipation Clinical Trials

Study Intestinal Complaints During Chemotherapy.

Start date: September 1, 2023
Phase:
Study type: Observational [Patient Registry]

Study intestinal complaints during chemotherapy. A prospective study into intestinal complaints in patients undergoing chemotherapy treatment. A pre and post implementation design is used to establish if eating two kiwi fruits per day can prevent constipation.

NCT ID: NCT05905926 Enrolling by invitation - Clinical trials for Irritable Bowel Syndrome With Constipation (IBS-C)

Safety Study of Tenapanor for the Treatment of Pediatric Patients (6 to Less Than 18 Years Old) With IBS-C

Start date: February 17, 2023
Phase: Phase 3
Study type: Interventional

Open-label long-term safety study of tenapanor in pediatric patients with IBS-C.

NCT ID: NCT05899062 Enrolling by invitation - Constipation Clinical Trials

Telerehabilitation-based Exercise Training in Constipated Patients

Start date: June 1, 2023
Phase: N/A
Study type: Interventional

It has been determined that three out of every four people in the society do not have sufficient physical activity level, and 54% of individuals between the ages of 15-19 and over 55 are sedentary. As a result of this, the probability of encountering the problem of constipation may increase. There are many methods in the treatment of constipation. When examined in terms of exercise interventions, it was found that 150 minutes of moderate-intensity exercise per week was effective in reducing the symptoms of constipation, while aerobic exercise performed less than 140 minutes/week did not improve the symptoms of constipation. It has been reported that individuals who received defecation training were particularly successful in the management of constipation symptoms. In our study, it is aimed to examine the effectiveness of exercise interventions for constipation. In addition, to the best of our knowledge, no study has been conducted on the effectiveness of a telerehabilitation-based education and exercise program in patients with constipation. It is thought that the management of patients with constipation with telerehabilitation will ease the burden on the health system, while it will save the patient cost and time, and will facilitate the access to treatment for patients living in geographically disadvantaged areas. In addition, it is important for patients to participate in distance rehabilitation studies in their professional and social lives, as it is an innovative treatment approach. It is thought that the exercises for constipation applied in addition to the training program may be a more effective method in improving the quality of life and colonic motility of the patients.